- Home
- MKTX vs BIO Comparison
MKTX vs BIO Comparison
Compare MKTX & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTX
- BIO
- Stock Information
- Founded
- MKTX 2000
- BIO 1952
- Country
- MKTX United States
- BIO United States
- Employees
- MKTX N/A
- BIO 8030
- Industry
- MKTX Investment Bankers/Brokers/Service
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- MKTX Finance
- BIO Industrials
- Exchange
- MKTX Nasdaq
- BIO Nasdaq
- Market Cap
- MKTX 8.5B
- BIO 9.6B
- IPO Year
- MKTX 2004
- BIO N/A
- Fundamental
- Price
- MKTX $220.50
- BIO $342.73
- Analyst Decision
- MKTX Hold
- BIO Strong Buy
- Analyst Count
- MKTX 10
- BIO 4
- Target Price
- MKTX $261.30
- BIO $414.00
- AVG Volume (30 Days)
- MKTX 408.7K
- BIO 159.4K
- Earning Date
- MKTX 02-06-2025
- BIO 02-13-2025
- Dividend Yield
- MKTX 1.34%
- BIO N/A
- EPS Growth
- MKTX 12.13
- BIO N/A
- EPS
- MKTX 7.39
- BIO N/A
- Revenue
- MKTX $811,941,000.00
- BIO $2,580,209,000.00
- Revenue This Year
- MKTX $11.64
- BIO N/A
- Revenue Next Year
- MKTX $9.93
- BIO $2.92
- P/E Ratio
- MKTX $29.84
- BIO N/A
- Revenue Growth
- MKTX 10.74
- BIO N/A
- 52 Week Low
- MKTX $192.42
- BIO $262.12
- 52 Week High
- MKTX $296.68
- BIO $387.99
- Technical
- Relative Strength Index (RSI)
- MKTX 34.29
- BIO 53.95
- Support Level
- MKTX $210.77
- BIO $334.57
- Resistance Level
- MKTX $228.25
- BIO $355.05
- Average True Range (ATR)
- MKTX 4.45
- BIO 10.12
- MACD
- MKTX 1.01
- BIO 1.22
- Stochastic Oscillator
- MKTX 47.07
- BIO 61.48
About MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Borse Group in 2020 adding to its product offerings.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.